Strategic Blueprint LLC Sells 417 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Strategic Blueprint LLC trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 9.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,971 shares of the biopharmaceutical company’s stock after selling 417 shares during the period. Strategic Blueprint LLC’s […]
More Stories
Cameco Target of Unusually Large Options Trading (NYSE:CCJ)
Cameco Co. (NYSE:CCJ – Get Free Report) (TSE:CCO) was the target of some unusual options trading on Thursday. Stock investors...
Evans Bancorp (NYSEAMERICAN:EVBN) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Evans Bancorp (NYSEAMERICAN:EVBN – Free Report) in a report published on Wednesday. The firm...
N4 Pharma (LON:N4P) Trading Up 23.8% – Still a Buy?
Shares of N4 Pharma Plc (LON:N4P – Get Free Report) were up 23.8% during trading on Wednesday . The stock...
Iconic Minerals (CVE:ICM) Stock Price Up 33.3% – Here’s What Happened
Iconic Minerals Ltd. (CVE:ICM – Get Free Report)’s stock price rose 33.3% on Wednesday . The stock traded as high...
Ramsay Health Care (OTCMKTS:RMSYF) Shares Up 4.7% – Should You Buy?
Shares of Ramsay Health Care Limited (OTCMKTS:RMSYF – Get Free Report) rose 4.7% on Friday . The stock traded as...
Antofagasta (OTCMKTS:ANFGF) Trading Down 0.5% – Here’s Why
Antofagasta plc (OTCMKTS:ANFGF – Get Free Report)’s share price was down 0.5% during mid-day trading on Friday . The company...